Health Catalyst (HCAT)
(Delayed Data from NSDQ)
$3.82 USD
0.00 (0.00%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $3.82 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth C Momentum A VGM
Fundamental Charts
About Market Cap
As of the previous market close, Health Catalyst, Inc. has a market cap of $265.88M, which represents its share price of $3.82 multiplied by its outstanding shares number of 69.60M. As a small-cap company, HCAT's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
HCAT 3.82 0.00(0.00%)
Will HCAT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for HCAT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HCAT
OPRX Delivers Solid Q1 Earnings: But Can It Sustain the Momentum?
VEEV Rises 29% in 3 Months: Should You Buy the Stock Now or Wait?
HCAT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Can OptimizeRx Maintain Profit Growth Amid Evolving Pharma Spend?
Health Catalyst (HCAT) Upgraded to Buy: Here's Why
Health Catalyst (HCAT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Other News for HCAT
Health Catalyst to Announce Second Quarter 2025 Operating Results and Host Conference Call on ...
Health Catalyst (HCAT): Evercore ISI Group Updates Price Target | HCAT Stock News
Deep Dive Into Health Catalyst Stock: Analyst Perspectives (5 Ratings)
Accelerating Measurable Improvement Through Actionable Insights: Health Catalyst Announces the ...
Health Catalyst (HCAT) Faces Downgrade Amid Financial Pressures | HCAT Stock News